Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-062955

Options or other derivatives

  • Director acquired 46,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hatfield Jeffrey S. Director 2020-12-09 Grant or award · Stock Option (Right to Buy) +46,500 46,500 D
Loading xslF345X03/doc4.xml…